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Abstract
Background: Gastric diseases are a worldwide problem in modern society, as reported in the USA, in the range of
0.5–2 episodes/year/person and an incidence of 5–100 episodes/1000/week according to seasons and age. There is
convincing evidence that oxidative stress is involved in the pathogenesis of acute gastric injury. Acid secreted from
gastric parietal cells determines mucosal injuries which in turn cause inflammation and oxidative stress. Consequent
inflammation produces free radicals by mitochondria thus causing lipid peroxidation, oxidative and acidic stress,
which can lead to cell apoptosis. Vitamin D3, the active form of vitamin D, may counteract intracellular cell death
and improve epithelial regeneration.
Methods: This study was planned to assess whether vitamin D3 is a protective factor against acid injury and
oxidative stress in gastric epithelial cells. Primary epithelial cells and GTL-16 cells have been used to test the effects
of Grisù® alone or in combination with vitamin D3 during oxidative stress or high acid exposition measuring cell
viability, ROS production, cellular adhesion time along with apoptotic, autophagic and survival pathways. The
combined effect of Grisù® and vitamin D3 was found more effective in counteracting the negative consequences of
oxidative stress and acidity conditions than some other gastroprotective agents, such as Maalox® or Gaviscon®.
Results: In case of oxidative stress or acidity condition the stimulation with Grisù® alone caused an improvement of
cell viability and a reduction of ROS production on epithelial gastric cells. In addition, the adhesion time of the cells
was improved. All these effects were increased by the presence of vitamin D3. Similar data were also observed in
primary gastric epithelial cells confirming the results obtained in GTL-16 cells.
Conclusions: These results suggest that Grisù® in combination with vitamin D3 may exert a gastroprotective effect
to maintain or restore the integrity of gastric epithelium through an antioxidant pathway, inhibiting apoptosis and
activating survival kinases. Moreover, the combination of Grisù® and vitamin D3 improves cell viability and decreases
ROS production compared to other gastroprotective agents combined with vitamin D3. All these data were
validated using primary cells isolated from gastric tissue.
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Background
The impact of gastric diseases (for example chronic gas-
tritis, duodenal and gastric ulceration, adenocarcinoma
and gastric MALT lymphoma) on human health is a
worldwide problem in modern society [1, 2]. For ex-
ample in the USA, studies have reported gastrointestinal
illness rates in the range of 0.5–2 episodes/year/person
and incidence of 5–100 episodes/1000/week according
to seasons and age. The number of episodes of gastro-
intestinal illnesses is similar in both 40-year-old studies
and in recent ones [3]. Human stomach is extremely vul-
nerable to various attacks; trauma can cause erosion and
mucosal epithelium damage which lead to gastrointes-
tinal tract bleeding and/or ulcer perforation and finally
worsen the original disease [4]. The gastrointestinal epi-
thelium is a fundamental barrier protecting the gastro-
intestinal mucosa from damage against the outside
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environment [4]. The cytoprotective functions against
damage may be accomplished in the early phase of
epithelial repair known as restitution [5–7], which is
the ability of epithelial cells to spread and migrate
across the basement membrane to repair the damage.
This event is the basis of repair of mucosae after in-
jury and is an important element to grant continuity
over broad areas within hours [8, 9]. This reparative
event occurs rapidly [10]. The damage to gastric mu-
cosa deriving from stress ulcer has been shown in
in vivo models to be possibly repaired within 24 h
[11]. Gastric acid (HCl) secreted from gastric parietal
cells has been reported to determine gastric mucosal
injuries such as peptic ulcer and to induce gastropa-
thy [12]. A prolonged exposition to strong acidic en-
vironment causes coagulation necrosis resulting from
the desiccating action of the acid on proteins in ex-
posed tissues. A mild gastritis condition is often asso-
ciated with overindulgence in food and alcohol or
stress and each episode causes more lasting damage,
eventually resulting in cellular injury which in turn
causes inflammation [13]. Consequent inflammation
produces free radicals which in turn create even more
tissue destruction [14, 15] eventually injuring DNA
and potentially leading to stomach cancer, which is
one of the most lethal malignancies known so far
[16]. In addition, HCl enhances the process of lipid
peroxidation in gastric mucosa [17]; the dissipation of
mitochondrial transmembrane potential thus induces
the production of reactive oxygen species (ROS) by
mitochondria causing lipid peroxidation [18, 19].
ROS, including H2O2, are a major cause of cellular
oxidative damage [20] and they play a critical role in
the pathogenesis of gastric disorders [2, 21]. Under
physiological conditions, gastric epithelium is exposed
to high levels of ROS, derived from physical, chemical, or
microbiological agents existing in gastric lumen, far higher
than in other tissues or biological fluids [22, 23]. Accumu-
lation of intracellular ROS is caused by incomplete reduc-
tion of oxygen [24] and this imbalance leads to oxidative
stress [24]. H2O2 is a stable, small and uncharged mol-
ecule, that freely diffuses through cell membranes. An ex-
cessive level of H2O2 causes apoptosis, necrosis, and other
oxidative damages [25]. When the lower esophageal
sphincter is weak, the acid unnaturally moves up into
the esophagus, causing gastroesophageal reflux disease
(GERD), whose cardinal symptom is heartburn, mainly oc-
curring postprandially.
Therapeutic strategies aim at treating both symptoms
and epithelial damage with chemical or mechanical ap-
proaches. However, a new molecular approach can be
hypothesized in order to counteract intracellular mecha-
nisms leading to cell death and to improve epithelial
regeneration.
Recently, a crucial role for vitamin D in digestive sys-
tem health has been described. Low levels of active form
of vitamin D (vitD3) are related to poor stomach empty-
ing as well as bloating and constipation or “irritable
bowel”. Vitamin D links to several target tissues in the
digestive system, in the oral region, epithelial cells of the
oral cavity, tongue and gingiva, teeth odontoblast and
ameloblast precursor pulp and stratum intermedium
cells; in the salivary glands: epithelial cells of striated
ducts and granular convoluted tubules, intercalated
ducts and acinar cells, as well as myoepithelial cells; in
the stomach: neck mucous cells of gastric glands, endo-
crine cells of the antrum, and muscle cells of the pyloric
sphincter; in the small and large intestine: absorptive
and crypt epithelial cells; in the pancreas, predominantly
islet B-cells [26]. In gastric mucosa, vitamin D appears
to have high preventive and therapeutic potentials by
stimulating cell proliferation and differentiation [27],
and is able to regulate endocrine and paracrine secretion
of gastrin with secondary effects, for instance on parietal
cell HCl and pepsinogen secreting chief cells [26]. In iso-
lated perfused stomach of vitamin D-deficient rats, gas-
trin and gastric somatostatin secretion is impaired [27].
Moreover, vitamin D3 has been shown to act on smooth
muscle cells in pyloric region and in large areas of small
intestine [26]. The activity of vitamin D3 is mediated by
vitamin D receptor (VDR) [28], whose expression has
been described in many different tissues including epi-
thelial cells from stomach antrum to duodenum [26].
VDR is a member of the nuclear receptor superfamily
which has been shown to be mostly localized in nuclear
environment by radiolabeling studies [29], although
there is also evidence of their existence in the cytoplasm
[30], especially in the absence of ligands and serum in
cell culture. Binding its receptor, vitamin D3 causes a
variety of downstream events, including a protective role
against oxidative stress [31], regulation of autophagic
pathways [32], and the interplay between apoptosis and
survival pathways [31]. In this context vitamin D3 may
have beneficial effects on gastric health. For this reason,
its use could be of greater efficacy in association with
other gastroprotective agents like raft-forming alginates,
buffers, polysaccharides and biophenols (Grisù®) when
compared to other gastroprotectants (e.g. Maalox® or
Gaviscon®).
Since VDR/vitD signaling plays a role in growth con-
trol of gastric cells, it can be expected that an adequate
vitamin D status is required to achieve benefits not only
in cancer prevention but also in many other pathologies.
Our aim is to demonstrate whether the active form of
vitamin D (vitD3) can act as a protective factor against
oxidative stress in cultured gastric epithelial cells in a
mutually supportive manner with other gastroprotective
agents.
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Methods
Cell culture
GTL-16 cell line is a clonal line derived from a poorly
differentiated gastric carcinoma cell line [33] and is
widely used as a model of gastric epithelial cells. This
cell line was donated by the Laboratory of Histology of
the University of Eastern Piedmont. Cells were cultured
in Dulbecco’s Modified Eagle Medium (DMEM) supple-
mented with 10 % foetal bovine serum (FBS), 1 %
penicillin-streptomycin in incubator at 37 °C, 5 % CO2.
The cells for the experiments were plated in a different
ways; to study cell viability (MTT test) and cell prolifera-
tion (crystal violet staining) 1x104 cells were plated on
96 well-plates; to analyze radical oxygen species (ROS)
production 1x105 cells were plated on 24 well-plates; to
perform immunohistochemistry studies 0.5x104 cells
were placed in Culture Slide (BD, Bedford, MA, U.S.A.)
with 4 chambers; to analyze the intracellular pathways
through Western blot analysis the cells were plated on
60 mm dishes until confluence. Before stimulations the
cells were maintained in DMEM without red phenol and
FBS and supplemented with 1 % penicillin/streptomycin,
2 mM L-glutamine and 1 mM sodium pyruvate in an in-
cubator at 37 °C, 5 % CO2, and 95 % humidity for 18 h.
Then the cells were treated with different agents in
DMEM without red phenol and supplemented with
0.5 % FBS, 1 % penicillin/streptomycin, 2 mM L-glutamine
and 1 mM sodium pyruvate.
Experimental protocol
The cells were used to study two different biological as-
pects. In the first set of experiments, the influence of a
new alginate preparation (Grisù®) alone or in combin-
ation with 100 nM vitD3 on cellular adhesion was ana-
lyzed by measuring adhesion time through crystal violet
assay and vitronectin/fibronectin staining by Western
Blot. In this case the agents were used to coat the plates
or chamber-slides for 20 min in incubator at 37 °C be-
fore seeding the cells. The adhesion time of GTL-16 (a
specific number of cells) was checked from 2 min to
720 min (2 min, 5 min, 15 min, 30 min, 60 min, 90 min,
240 min, 720 min) [34]. In the absence of coating, the
cells were adherent until 3–5 h.
In the second set of experiments the same agents were
added directly in the cells plated for the experimental
protocol without coating. Maalox®, Gaviscon® and a pro-
ton pump inhibitor (PPI) were tested in the preliminary
experiments alone or in combination with 100 nM vitD3
to compare the efficacy to Grisù® alone or in combin-
ation with 100 nM vitD3 on cell viability. In addition, all
these agents were also tested in presence of 200 μM
H2O2 or HCl to determine the effects during oxidative
stress or gastric acidity. The time of stimulation was
from 15 min to 24 h (15 min, 30 min, 60 min, 90 min,
3 h, 24 h). Since the maximum effect was observed after
1 h of treatment this condition was maintained for all
successive experiments. Moreover, Maalox®, Gaviscon®
and PPI had negative effects on cell viability which were
more important in presence of H2O2 or HCl. In the suc-
cessive experiments these agents were not tested.
Agents preparations
Grisù® is a dietary supplement that combines the proper-
ties of calcium alginate in a buffer solution, resulting
from alkaline salts useful to counteract situations of high
acidity, with a tyndalized probiotic (Pylopass®) and an
extract of prickly pear and olive leaves (Mucosave®): the
extract of prickly pear is useful for its emollient and
soothing characteristics at the level of the digestive
system.
Grisù®, composed by Mucosave® (0.83 mg/ml), cal-
cium alginate (1.66 mg/ml), magnesium hydroxide
(2.66 mg/ml), potassium citrate (4.66 mg/ml) and
Pylopass™ (0.66 mg/ml), was dissolved according to
solubility reported in manufacturer’s instructions, dir-
ectly in the DMEM without red phenol and FBS but
supplemented with 1 % penicillin/streptomycin, 2 mM L-
glutamine and 1 mM sodium pyruvate when used for the
adhesion study. Instead for the second set of experi-
ments Grisù®, Maalox®, Gaviscon® and PPI were dis-
solved directly in the medium used for stimulations
respecting the solubility reported in manufacturer’s
instructions. In both sets of experiments, the solu-
tions were used without dilutions. The active form of
vitamin D (1,25-dihydroxyvitamin D3, catalog number:
D1530, Sigma-Aldirch, Milan, Italy) was prepared in
absolute ethanol at 10-3 M and used at final concen-
tration of 100 nM prepared directly in medium. The
percentage of ethanol was less than 0.001 %. HCl was
used to prepare an acidified medium (pH 4) and
added to the cells without dilution.
MTT test
At the end of each stimulation, MTT-based In Vitro
Toxicology Assay Kit (Sigma-Aldrich) was used to deter-
mine cell viability, as previously described [31]. Cells
were incubated with 1 % MTT dye for 2 h at 37 °C in in-
cubator, and then, the purple formazan crystals were dis-
solved in equal volume of MTT Solubilization Solution.
Cell viability was determined by measuring the absorb-
ance through a spectrometer (VICTORX3 Multilabel
Plate Reader) at 570 nm with correction at 690 nm, and
calculated by comparing results to control cells (100 %
viable).
Crystal violet staining
The cells treated with Grisù® alone or in combination
with vitD3 were also analyzed by crystal violet staining
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to study adhesion. GTL-16 cells at the end of each time-
point were fixed with 1 % glutaraldehyde for 15 min at
RT, washed and stained with 100 μl of 0.1 % crystal vio-
let for 20 min at RT. The multi-well plates were rinsed,
dry and the images of adherent aqueous cells were taken
and analyzed by ImageJ software. To obtain cell number
estimation 100 μl of 10 % acetic acid were added and
mixed before reading the absorbance at 595 nm through
a spectrometer (VICTORX3 Multilabel Plate Reader).
The number estimation was calculated by comparing re-
sults to the control cells (Control T0).
ROS production
The rate of superoxide anion release was measured
using a standard protocol [31] and determined as a
superoxide dismutase-inhibitable reduction of cyto-
chrome C. In both treated and untreated cells, 100 μl of
cytochrome C were added, and in another sample,
100 μL of superoxide dismutase were also added for
30 min in incubator (all substances from Sigma-
Aldrich). The absorbance was measured at 550 nm in a
spectrometer (VICTORX3 Multilabel Plate Reader) and
the O2 was expressed as means ± SD% of nanomoles per
reduced cytochrome C per microgram of protein com-
pared to control [35].
Western Blot
GTL-16 cells were lysed in iced Complete Tablet Buffer
(Roche) supplemented with 2 mM sodium orthovanadate
and 35 μg of proteins resolved on 15 or 5 % SDS-PAGE
Fig. 1 Adhesion time analysis of GTL-16. In a on the left, optical microscopy images of adherent GTL-16 taken at original magnification 20X. On
the right, the number of adherent cells for each treatment is reported. The ratio reports a mean ± (SD) (%) of adherent cells counted in
12 different areas. Data reported are means of 5 biological replicates. G = Grisù®; G + V = co-stimulation with Grisù® and vitD3. b, c, d p < 0.05 vs a; a, f, e
p < 0.05 vs d; e p < 0.05 vs b; f p < 0.05 vs c. In b on the left, optical microscopy images of the cells treated with Grisù® alone or in combination with
vitD3 after 2 min and 90 min are shown. The scale reported in the first picture is to be considered valid for all images. On the right, the cell counting
of adherent cells during time (at 2 min, 5 min, 15 min, 30 min, 60 min, 90 min, 240 min, 720 min) is reported. The ratio reports a mean ± (SD) (%) of
adherent cells counted in 12 different areas of 5 biological replicates. The abbreviations are the same reported in a. All samples are
significant p < 0.05 vs control
Table 1 Cell counting of crystal violet staining
Time (min) Control G G + V
2 2.67 ± 1.63 8.5 ± 2.12 a 11.33 ± 3.05 a
5 2.17 ± 0.98 7 ± 2.83 9.67 ± 4.04 a
15 5.5 ± 2.38 9.5 ± 3.54 17.5 ± 3.54 a
30 12 ± 2.83 22 ± 2.83 a 26.5 ± 0.71 a
60 19.67 ± 2.52 42 ± 2.84 a 60 ± 2.83 a
90 38 ± 2 55 ± 3 a 70 ± 2 a
240 55.33 ± 3.05 79.67 ± 3.215 a 87 ± 2 a
720 94.33 ± 2.082 95.68 ± 1.528 97.33 ± 1.15
Data are shown as a mean ± (SD) (%) of adherent cells counted in 12 different
areas of 4 technical replicates. a p < 0.05 vs control. The abbreviations are the
same described in figure legends
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gels. Polyvinylidene fluoride membranes (PVDF, GE
Healthcare Europe GmbH, Milan, Italy) were incu-
bated overnight at 4 °C with specific primary antibody:
anti-phospho-ERKThr202/Tyr204 (1:1000, Cell-SIgnaling),
anti-VDR (1:250, Santa-Cruz), anti-Annexin V (1:1000,
Sigma), anti-Beclin1 (1:250, Santa-Cruz), anti-Caspase 8
(1:400, Sigma), anti-Bax (1:200, Santa-Cruz), anti-
Vitronectin (1:250, Santa-Cruz) and anti-Fibronectin
Fig. 2 Western blot and densitometric analysis of vitronectin and fibronectin. G = Grisù®; V = vitD3; G + V = Grisù® combined with vitD3. The ratio
reports a mean ± (SD) (%) of 5 biological replicates normalized to control values (line 0 %). In a densitometric analysis of vitronectin normalized to
control values during time (from 2 to 240 min). a, b, c, d, e, f, h, i, j, k, l, m, n, o, p, q, r, s, t, u p < 0.05 vs control; a, b p < 0.05 vs c; e p < 0.05 vs f; i
p < 0.05 vs g; j, k p < 0.05 vs l; m, n, p < 0.05 vs o; p, q p < 0.05 vs r; s, t p < 0.05 vs u. In b densitometric analysis of fibronectin normalized to
control values during time (from 2 to 90 min). d, e, f, g, h, i, j, k, l, m, n, o, p, q, r p < 0.05 vs control; g, h p < 0.05 vs i; j, k p < 0.05 vs l; m, n
p < 0.05 vs o; p, q p < 0.05 vs r. In c an example of Western blot of protein extracts analyzed by immunoblotting with specific antibodies
against the indicated proteins
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(1:250, Abcam, UK). The protein expressions were nor-
malized and verified through β-actin detection (1:5000;
Sigma, Milan, Italy).
Immunocytochemistry
The cells cultured in chamber slides were fixed using
an iced fixative solution (3.7 % formaldehyde, 3 % su-
crose in PBS 1X) for 20 min at RT, permeabilized
with ice 0.5 % Triton X-100 in PBS 1X in ice at 4 °C
for 20 min, incubated with 3 % hydrogen peroxide in
PBS 1X for 8 min and then maintained in a blocking
solution (PBS 1X with 3 % albumin from bovine
serum-BSA, Sigma, Milan, Italy) for 1 h in at RT, as
previously described [36]. After this time the slides
were incubated overnight at 4 °C in a humidified
chamber with specific primary antibody VDR receptor
(1:50). Then chamber slides were incubated before
with diluted biotinylated secondary antibody solution
(Dako Italia, Milan, Italy), then with VECTASTAIN®
ABC Reagent (Dako Italia, Milan, Italy), and finally in
peroxidase substrate solution (Peroxidase/DAB, Dako
Italia, Milan, Italy), and counterstained with Mayer’s
hematoxylin. The number of positive cells was calcu-
lated as described elsewhere [37]; briefly, 12 different
areas (1 mm2) randomly selected from each section
were taken, and the number of signals was deter-
mined using ImagePro 3 software (NIH, Bethesda, US).
The results are expressed as means ± SD (%).
Statistical analysis
Results are expressed as means ± SD of at least 5
biological replicates for each experimental protocol
and each replicate was reproduced 3 times. One-way
ANOVA followed by Bonferroni post hoc test was
used for statistical analysis. Mann-Whitney U test was
used to compare percentages of responses. P-value <0.05
was considered statistically significant.
Results
Influence of Grisù® alone or in combination with vitD3 on
adhesion capacity
Grisù® acts as a physical barrier for gastric epithelial cells
and protects against hyperacidity. The first set of experi-
ments was performed because of a difference in cell
adhesion after 4 h in the sample treated with Grisù®
(85.17 ± 2.25 %) compared to control (70.63 ± 2.12 %,
p < 0.05) (Fig. 1a). This augmented number of adher-
ent cells was more evident after 24 h (99.2 ± 0.72 %
compared to control 89.33 ± 3.51 %). The presence of
vitD3 improves this effect (at 4 h 88.07 ± 2.1 %; at
24 h 110.6 ± 1.25 %). Since this time is more suitable
to explain the influence of Grisù®, the time-point was
changed and Grisù® alone or in combination with vitD3
was used to coat the plates. As reported in Fig. 1b and
Table 1, in crystal violet staining, the number of adherent
GTL-16 cells was time-dependent and in presence of
Grisù® alone significantly increased (p < 0.05) starting from
2 min after seeding (8.5 ± 2.12 % compared to control
2.67 ± 1.63 %). This increase was enhanced in presence of
vitD3 (of about 33 % compared to Grisù® alone, p < 0.05).
All these effects were more evident in the course of time
(p < 0.05) and after 12 h almost all of the cells were at-
tached (p < 0.05). Vitronectin and Fibronectin, two extra-
cellular matrix glycoproteins well-known to be involved in
adhesion, were analyzed by Western Blot, to explain the
mechanism involved. As reported in Fig. 2a and c,
Vitronectin expression assessed by Western blot and
densitometric analysis, showed an increase in a time-
dependent manner and the presence of Grisù® starting
from 15 min was able to improve this expression
(1.93 ± 0.9 %, p < 0.05) compared to control. The presence
of co-stimulation with vitD3 was able to amplify the effect
of Grisù® alone starting from 15 min (4.69 ± 0.65 %) and
this amplified effect was maintained for the entire test
time, being evident at 90 min (p < 0.05) compared to
Grisù® alone (of about 78 %). The effect of vitD3 alone was
also analyzed, but did not show a significant increase on
vitronectin expression up to 60 min (18.06 ± 1 %
compared to control), thus showing the significant
ability of vitD3 to improve the effect of Grisù®. The
administration of Grisù® combined with vitD3 after
4 h treatment was able to improve the Vitronectin
expression according to the data observed in crystal
violet staining (p < 0.05).
Similar time-dependent effects were also observed in
Fibronectin expression, in GTL-16 treated with Grisù®
alone or in combination with vitD3, confirming the role
of vitD3 in modulating the capacity of Grisù®. These data
obtained by Western Blot and densitometric analysis are
shown in Fig. 2b and c.
Fig. 3 Time course of cell viability in GTL-16. The effects of vitD3 (V),
Grisù® (G) and Grisù® combined with vitD3 (G + V) vs control (line 0 %)
from 15 min to 24 h are reported. Data represent as a mean ± (SD) (%)
of 6 biological replicates. a, b, c, d, e, f, g, j, k, l, m, n, o, p; p < 0.05 vs
control; a, b p < 0.05 vs c; c, d, e p < 0.05 vs f; c, f, h p < 0.05 vs i; i, j, k, o,
r p < 0.05 vs l; n p < 0.05 vs o; o, p p < 0.05 vs r
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Mechanisms induced on cultured GTL-16 cells by Grisù®
alone or in combination with vitD3
MTT test was performed on a time-course study to de-
termine the best stimulation time for the influence of
Grisù® alone or in presence of 100 nM vitD3 on cell
viability. As reported in Fig. 3, the maximum effect of
Grisù® alone was observed after 1 h of stimulation
(20.55 ± 1.99 %, p < 0.05) and in presence of vitD3 this
effect was amplified of about 58 %, (p < 0.05). For this
reason, this time of stimulation was maintained for all
successive experiments.
In order to clarify the efficacy of Grisù® alone and in
combination with 100 nM vitD3 on cell viability, on cell
proliferation and on ROS production in gastroprotec-
tion, all the following experiments were performed in
presence or absence of pretreatment for 30 min with
200 μM H2O2 or HCl. As reported in Fig. 4 the pre-
treatment for 30 min with 200 μM H2O2 or HCl caused
a significant reduction (p < 0.05) of cell viability and cell
proliferation and increased ROS production (p < 0.05)
compared to control. Grisù® alone was able to counteract
the negative effects exerted by H2O2 or HCl on cell viabil-
ity, cell proliferation and ROS production (p < 0.05); in
particular, the most evident beneficial effects were ob-
served in reversing the influence exerted by HCl. In pres-
ence of the combination with 100 nM vitD3 the beneficial
effects were amplified (p < 0.05) maintaining the efficacy
in counteracting the influence of HCl. The apoptotic (in
particular Annexin V, Bax, Caspase 8), autophagic
(Beclin 1) and survival (ERK/MAPK) pathways were
investigated to explain the intracellular mechanisms
involved in the protective actions induced by Grisù®
alone or in combination with 100 nM vitD3. In addition,
the VDR receptor was analyzed to study the role of vitD3
in all these effects. Western blot and densitometric ana-
lysis (Fig. 5 and Additional file 1) showed a significant
increase of Annexin V, Bax and caspase-8 expressions
(p < 0.05) compared to control in presence of pre-
treatment with 200 μM hH2O2 or HCl alone and the
maximum effects were observed with HCl. On the
contrary the markers of autophagy and survival pathways
were maintained at a basal level. Either Grisù® or vitD3
Fig. 4 Effects of Grisù® alone or in combination with vitD3 during
acidity and oxidative stress. G = Grisù®; V = vitD3; G + V = Grisù®
combined with vitD3. Data represent a mean ± (SD) (%) of 6
biological replicates. In a cell viability: a, b, c, d, e, f, g, h, i p < 0.05 vs
control (line 0 %); c p < 0.05 vs a; e, f p < 0.05 vs d; f p < 0.05 vs e; h, i
p < 0.05 vs g; i p < 0.05 vs h; i p < 0.05 vs f. In b cell counting: c, d, e,
f, g, h, i, j p < 0.05 vs control; e p < 0.05 vs c; e p < 0.05 vs d; h p <
0.05 vs g; h p < 0.05 vs f; k, j p < 0.05 vs i; k p < 0.05 vs j; k p < 0.05 vs
h. In c ROS production: a, c, d, e, f, g, h, i, p < 0.05 vs control (line
0 %); c, b p < 0.05 vs a; f, e p < 0.05 vs d; f p < 0.05 vs e; i, k p < 0.05
vs g; i p < 0.05 vs h
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alone caused an increase in ERK1/2 and VDR expression
compared to control (p < 0.05). The combination of Grisù®
and vitD3 amplified (p < 0.05) the effects on ERK1/2 and
VDR expressions (25.26 ± 0.64 % and 39.12 ± 3.46 %,
respectively) compared to Grisù® (10.31 ± 0.59 % and
0.33 ± 1.15 %, respectively) or vitD3 alone (20.96 ± 2.05 %
and 29.48 ± 1.34 %, respectively). The same stimulations
performed after the treatments with 200 μM H2O2 or
HCl, were able to reverse the negative effects acting on
the expression of ERK1/2 and Beclin 1; in particular the
combination of Grisù® and vitD3 was able to amplify the
activation of autophagic and survival pathways. In
addition, this combination was able to improve the reduc-
tion of the apoptotic marker, such as Annexin V, Bax and
caspase 8.
Finally, the involvement of VDR in the beneficial ef-
fects above described was also confirmed by immuno-
cytochemical staining (Fig. 6) and by Western Blot
analysis (Additional file 1).
The effects of combination of Grisù® and vitD3 were
compared to other gastroprotective agents on cell viabil-
ity and ROS production, to confirm their ability to pro-
tect the epithelial gastric cells from oxidative stress or
acidity injury. As reported in Fig. 7, the combination of
Grisù® with vitD3 was able to induce the maximal benefi-
cial effects on cell viability and ROS production com-
pared to other gastroprotective agents alone (Maalox®,
Gaviscon® or PPI, p < 0.05). In addition, in presence of
oxidative stress caused by H2O2 or HCl acidified
medium, the combination of Grisù® with vitD3 was able
to positively modulate these negative conditions and sig-
nificantly reduce ROS production. This effect was sig-
nificantly better if compared to Maalox®, Gaviscon® and
PPI.
In some additional tests, vitD3 was added to other gas-
troprotective agents (Maalox®, Gaviscon® and PPI) and
the effects have been compared to those induced by
Grisù® combined with vitD3. As shown in Fig. 7, Grisù®
Fig. 5 Western blot and densitometric analysis of apoptotic, autophagic and survival pathways. The images and data reported are obtained from
5 biological replicates. G = Grisù®; V = vitD3; G + V = Grisù® combined with vitD3. Densitometric analysis are expressed as means ± (SD) (%)
normalized to control values (defined as 0 %). Caspase 8 p < 0.05: a, d, h, k vs control; e, f, g vs d; g vs k; f, j vs b; a, k vs c; i, j, k vs h; c, i, j vs k; e, j
vs a. Beclin p < 0.05: d, f, g, h, j, k vs control; g, k vs c; e, f, g vs d; e, k vs g; f, j vs b; i, j, k vs h; i, j vs k; i vs a. ERK: a, b, c, e, f, g, i. j, k vs control; e vs
g; i vs k; a, g, k vs c; e, f, g vs d; i, j, k vs h; f, j vs b; e, i vs a
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with vitD3 showed greater effectiveness to counteract
the negative effects of oxidative stress and acidity condi-
tion on cell viability and ROS release compared to other
gastroprotectants.
Similar data were also observed in primary gastric cell
cultures, where Grisù® with vitD3 was able to counteract
more effectively than other gastroprotectants, the nega-
tive effects of oxidative and acidic stress.
Validation in primary epithelial cells
Further experiments were carried out in primary gastric
epithelial cells, in order to confirm previously obtained
results about the protective effects exerted by Grisù®
alone or combined with vitD3 during oxidative and acid-
ity injury. Method used to isolate the primary cell cul-
tures is described in Additional file 2. Other methods
were the same used in GTL-16 cells experiments. Some
results on primary gastric cells were reported in
Additional file 2. Particularly, the improvement of adhe-
sion properties induced by Grisù® combined with vitD3;
the beneficial effects on cell viability and ROS produc-
tion in counteracting H2O2 or HCl oxidative injury; the
involvement of survival kinase in preventing apoptosis,
are shown.
Here are reported two of most important effects of
Grisù alone and combined with vitD3 on cell viability
and ROS production. As reported in Fig. 8a the time-
course study confirms that Grisù® alone and Grisù®
combined with vitD3 are able to enhance cell viability in
similar manner to what observed in GTL-16. The max-
imum effect was observed after 1 h 30 min (p < 0.05).
So, time of stimulation was maintained for all subse-
quent experiments. Finally, in primary gastric cells have
been also confirmed the efficacy of Grisù® alone and
combined with vitD3 compared to others gastroprotec-
tants to prevent the damage induced by oxidative stress
and acidity. As reported in Fig. 8b, vitD3 can modulate
the negative effects on ROS production only in presence
of Grisù®. This effect was also observed in GTL-16 cells.
Therefore, it can be hypothesized that Grisù® could act
like a substrate capable of promoting the effects of
vitD3.
Discussion
The integrity of gastrointestinal epithelium and mucosa
is known to be maintained by a number of secreted fac-
tors [38] and mediated by rapid proliferation and migra-
tion of mucosal epithelial cells [4] to resurface epithelial
defects after various forms of mucosal epithelium injury
[4] and to establish a barrier against the stress inducers.
As reported in literature in several in vitro and in vivo
studies, these factors protect gastric mucosal epithelium
from a variety of noxious agents, including bacterial
toxins, chemicals and drugs [4]. Epithelial migration,
which is a fundamental phase in the healing process
after gastric ulcer, is characterized by complex alterations
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in adhesion between cells and the extracellular matrix
[39]. In this study the effects of vitD3 on an in vitro ex-
perimental model of gastric cells have been observed.
Findings of this work demonstrate that vitD3 can exert
beneficial effect on gastric cells in terms of improved via-
bility and adhesivity or reduced ROS production. More-
over, this study permits to demonstrate that Grisù® alone
is able to improve the adhesivity of cells, reducing the time
of action (starting from 2 min from seeding, also mea-
sured by cell counting) but this effect is amplified by the
presence of vitD3. Moreover, we have found out that this
effect is crucial on cells migration and that two im-
portant extracellular matrix glycoproteins, Vitronectin
and Fibronectin, are involved in this effect mediated
by Grisù® both alone and in presence of vitD3. This
consideration is even more important because it indicates
Fig. 7 Cell viability and ROS production in GTL-16 treated with other gastroprotectants with vitD3. G = Grisù®; V = vitD3; G + V = co-stimulation
with Grisù® and vitD3. Data reported are expressed as means ± (SD) (%) of 5 biological replicates. In a: a, b, c, d, f, g, h, i, j, k, l, m, n, o, p, r, u, v
p < 0.05 vs control (line 0 %); b, d, e, f, g, h, i, j, k, l, m, n, o, p, q, r, s, t, u, v p < 0.05 vs a; a, c, e, f, g, h, i, j, k, l, m, n, o, p, q, r, s, t, u, v p < 0.05 vs b;
g, h, m, n, s, t p < 0.05 vs c; i, j, o, p, u, v p < 0.05 vs d; g, h, i, j p < 0.05 vs e; h, j, p < 0.05 vs f; m, n, o, p p < 0.05 vs k; n, p p < 0.05 vs l; r, u, v p < 0.05 vs q.
In b: a, c, e, f, g, h, i, j, k, l, m, n, o, p, q, r, s, t, u, v p < 0.05 vs control (line 0 %); b, e, f, g, h, i, j, m, o, q, r, s, t, u, v p < 0.05 vs a; e, f, g, h, i, j, k, m, n, o, p, q,
r, s, t, u, v p < 0.05 vs b; g, h, m, s, t p < 0.05 vs c; i, j, o, p, u, v p < 0.05 vs d; o p < 0.05 vs k; t, u p < 0.05 vs q; v p < 0.05 vs r
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that vitD3 is able to improve the beneficial effects induced
by alginates, thus supporting data about the mechanism of
gastroprotection induced by alginates [40]. This hypoth-
esis is also supported by other in vitro studies where VDR
activation has been shown not only to enhance intracellu-
lar junctions but also to promote mucosal wound repair
and to mediate the activity of vitD3 thus inducing junction
proteins expression [41]. As observed by Miyazaki et al.,
the reparative events following acute gastric injury occur
rapidly [10]. There is evidence that oxidative stress plays
an important role in the pathogenesis of acute gastric in-
jury [42–44]. For example, the role of oxidative stress in
gastrointestinal pathogenesis was first described in acute
intestinal injury in ischemia/reperfusion models [42]. Fol-
lowing studies suggested that ROS are generally involved
in acute injury of the gastrointestinal tract [43, 44]. It is
noteworthy that experimental evidence shows how ROS
production or superoxide (O2
-) are induced both by
Fig. 8 Time-course of cell viability and ROS production in primary gastric cells. In a primary gastric cells treated with Grisù® alone or combined
with vitD3 analyzed at 15 min, 30 min, 1 h, 1 h 30 min, 3 h, and 24 h. V = vitD3; G = Grisù®; G + V = Grisù® combined with vitD3. Data are reported
as means ± (SD) (%) of 3 biological replicates. a, c, d, e, f, g, h, i, j, k, l, m, n, o, p, q, r p < 0.05 vs control (line 0 %); c p < 0.05 vs b; g, h p < 0.05 vs i;
j, k p < 0.05 vs l; m p < 0.05 vs o; p p < 0.05 vs r. In b the effect on ROS production of Grisù® combined with vitD3 was compared to the effects of
different gastroprotectants alone and with vitD3. The results are expressed as means ± (SD) (%) of 3 biological replicates. G = Grisù®; V = vitD3;
G + V = Grisù® combined with vitD3. a, e, f, g, h, i, j, k, l, m, n, o, p, q, r, s, t, u, v p < 0.05 vs control (line 0 %); e, f, g, h, i, k, l, m, o, p, q, r, s, t, u, v
p < 0.05 vs a; e, f, g, h, i, j, k, l, m, n, o, p, q, r, s, t, u, v p < 0.05 vs b; g, h, m, n, t p < 0.05 vs c; i, j, o, p, u, v p < 0.05 vs d; g, h, i, j p < 0.05 vs e; h, j
p < 0.05 vs f; v p < 0.05 vs q
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cellular exposure to an alkaline environment and/or by
acid injury [12, 44]. All these findings confirm the cyto-
toxic action both of ROS production and of acidic expos-
ure leading to cells apoptosis. It is well known that vitD3
may prevent cell death through modulation of the inter-
play between apoptosis and autophagy. This effect is
obtained by inhibiting superoxide anion generation, main-
taining mitochondria function and cell viability, activating
survival kinases, and inducing NO production [31]. Our
results show that Grisù® alone is able to improve both cell
viability and cell proliferation and in presence of vitD3
these effects are increased compared to control. In
addition, after H2O2 or HCl exposure, Grisù® in associ-
ation with vitD3 significantly reduced ROS production
and decreased cell viability loss, suggesting that cell dam-
age and cytotoxicity can be prevented by the combination
of Grisù® with vitD3. These results suggest that Grisù® in
combination with vitD3 may exert a better gastroprotec-
tive effect through an antioxidant pathway, inhibiting
apoptosis and activating survival kinases. Such effect was
stronger in preventing epithelial damage than what
observed using other gastroprotective agents such as
Gaviscon®, Maalox® or proton pump inhibitors.
Since GTL-16 is a cell line, further experiments were
carried out in primary cells to validate the observed re-
sults. Cells isolated from gastric tissue were used. The
results obtained from this new series of experiments
have allowed us to significantly confirm beneficial effects
of Grisù®, alone or in association with vitD3, to prevent
the oxidative and acid injury.
In conclusion, this work demonstrates for the first
time that vitD3 has a beneficial effect when combined
with an alginate-based gastroprotector agent on gastric
epithelial cells, joining the effects of a mechanical barrier
with the modulation of intracellular pathways in order
to maintain or restore the integrity of gastric epithelium.
Conclusion
These in vitro results suggest that Grisù® in combination
with vitD3 may exert a gastroprotective effect to main-
tain or restore the integrity of gastric epithelium through
an antioxidant pathway, inhibiting apoptosis and activat-
ing survival kinases better than other gastroprotective
agents.
However, further in vivo or research will be necessary
in order to assess, with histological and immunocyto-
chemical methods, the efficacy of Grisù® and vitD3 on
gastric mucosa undergoing oxidative and/or acidic
stress. The experimental data could thus provide a basis
for the execution of clinical studies.
The combination of Grisù® with vitD3 significantly de-
creased the reactive oxygen species production and de-
creased cell viability loss, suggesting that cell damage
and cytotoxicity can be reduced.
Additional files
Additional file 1: Figure S1. Western Blot and densitometric analysis in
GTL-16 cells. (DOCX 492 kb)
Additional file 2: Material and Methods; Results. Method: primary cell
culture. Results: evaluation of Grisù® in combination with vitD3 on
adhesion capacity (with 3 figures). (DOCX 338 kb)
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